These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1359070)

  • 1. Doxorubicin-loaded casein microspheres: protein nature of drug incorporation.
    Willmott N; Magee GA; Cummings J; Halbert GW; Smyth JF
    J Pharm Pharmacol; 1992 Jun; 44(6):472-5. PubMed ID: 1359070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of albumin and casein microspheres as a carrier for doxorubicin.
    Chen Y; Willmott N; Anderson J; Florence AT
    J Pharm Pharmacol; 1987 Dec; 39(12):978-85. PubMed ID: 2894445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition.
    Cummings J; Willmott N; Marley E; Smyth J
    Biochem Pharmacol; 1991 Jun; 41(12):1849-54. PubMed ID: 2039540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The consequences of doxorubicin quinone reduction in vivo in tumour tissue.
    Cummings J; Willmott N; Hoey BM; Marley ES; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2165-74. PubMed ID: 1472081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between reductive drug metabolism in tumour tissue of anthracyclines in microspherical form and anti-tumour activity.
    Willmott N; Cummings J; Marley E; Smyth JF
    Biochem Pharmacol; 1990 Mar; 39(6):1055-62. PubMed ID: 2322293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats.
    Willmott N; Chen Y; Goldberg J; Mcardle C; Florence AT
    J Pharm Pharmacol; 1989 Jul; 41(7):433-8. PubMed ID: 2570846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between tumour drug disposition and the antitumour activity of doxorubicin-loaded microspheres: implications for the drugs' in vivo mechanism of action.
    Cummings J; Willmott N; Marley EC; Smyth JF
    Biochem Pharmacol; 1993 Jun; 45(12):2550-3. PubMed ID: 8328991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.
    Willmott N; Cummings J
    Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Casein as a carrier matrix for 5-fluorouracil: drug release from microspheres, drug-protein conjugates and in-vivo degradation of microspheres in rat muscle.
    Latha MS; Jayakrishnan A; Rathinam K; Mohanty M
    J Pharm Pharmacol; 1994 Nov; 46(11):858-62. PubMed ID: 7897587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.
    Jones C; Burton MA; Gray BN
    Br J Cancer; 1989 May; 59(5):743-5. PubMed ID: 2736208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labeled with doxorubicin or protein A.
    Rettenmaier MA; Stratton JA; Berman ML; Senyei A; Widder K; White DB; DiSaia PJ
    Gynecol Oncol; 1987 May; 27(1):34-43. PubMed ID: 3570048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat.
    Teder H; Johansson CJ
    Anticancer Res; 1993; 13(6A):2161-4. PubMed ID: 8297129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ion-exchange microspheres as carriers for the anticancer drug doxorubicin: in-vitro studies.
    Chen Y; Burton MA; Codde JP; Napoli S; Martins IJ; Gray BN
    J Pharm Pharmacol; 1992 Mar; 44(3):211-5. PubMed ID: 1354725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response and toxicity of doxorubicin microspheres in a rat tumor model.
    Napoli S; Burton MA; Martins IJ; Chen Y; Codde JP; Gray BN
    Anticancer Drugs; 1992 Feb; 3(1):47-53. PubMed ID: 1623216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of covalent binding to intact DNA, RNA, and oligonucleotides by intercalating anticancer drugs using high-performance liquid chromatography. Studies with doxorubicin and NADPH cytochrome P-450 reductase.
    Cummings J; Bartoszek A; Smyth JF
    Anal Biochem; 1991 Apr; 194(1):146-55. PubMed ID: 1714250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma.
    Seymour LW; Ulbrich K; Steyger PS; Brereton M; Subr V; Strohalm J; Duncan R
    Br J Cancer; 1994 Oct; 70(4):636-41. PubMed ID: 7917909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.